These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1695440)

  • 41. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.
    Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
    Drugs R D; 2005; 6(6):371-84. PubMed ID: 16274260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 4-(Indolyl-3)-1-(benzimidazolonylalkyl)-piperidines, a novel group of potential antiallergy compounds.
    Freter K; Fuchs V; Barsumian E; Oliver JT
    Arzneimittelforschung; 1985; 35(1A):272-6. PubMed ID: 2580540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Substituted 6,7-dihydroimidazo[1,2-a]purin-9(4H)-ones.
    Temple DL; Yevich JP; Catt JD; Owens D; Hanning C; Covington RR; Seidehamel RJ; Dungan KW
    J Med Chem; 1980 Nov; 23(11):1188-98. PubMed ID: 6161252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological characteristics of Sho-seiryu-to, an antiallergic Kampo medicine without effects on histamine H1 receptors and muscarinic cholinergic system in the brain.
    Sakaguchi M; Iizuka A; Yuzurihara M; Ishige A; Komatsu Y; Matsumiya T; Takeda H
    Methods Find Exp Clin Pharmacol; 1996; 18(1):41-7. PubMed ID: 8721255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rocastine (AHR-11325), a rapid acting, nonsedating antihistamine.
    Nolan JC; Stephens DJ; Proakis AG; Leonard CA; Johnson DN; Kilpatrick BF; Foxwell MH; Yanni JM
    Agents Actions; 1989 Aug; 28(1-2):53-61. PubMed ID: 2571244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New antihistaminic N-heterocyclic 4-piperidinamines. 2. Synthesis and antihistaminic activity of 1-[(4-fluorophenyl)methyl]-N-(4-piperidinyl)-1H-benzimidazol-2-a mines.
    Janssens F; Torremans J; Janssen M; Stokbroekx RA; Luyckx M; Janssen PA
    J Med Chem; 1985 Dec; 28(12):1934-43. PubMed ID: 3934386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of antiallergic and anti-anaphylactic activity of ethanolic extract of Sanseveiria trifasciata leaves (EEST) in rodents.
    Andhare RN; Raut MK; Naik SR
    J Ethnopharmacol; 2012 Aug; 142(3):627-33. PubMed ID: 22683909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of passive cutaneous anaphylaxis by several histamine (H1) and serotonin antagonists in the rat.
    Metys J; Frycová H; Soucek R
    Agents Actions; 1988 Apr; 23(3-4):331-3. PubMed ID: 3394585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
    Carceller E; Merlos M; Giral M; Balsa D; Almansa C; Bartrolí J; García-Rafanell J; Forn J
    J Med Chem; 1994 Aug; 37(17):2697-703. PubMed ID: 7914928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1,2,4-Triazolo[4,3-a]quinoxaline-1,4-diones as antiallergic agents.
    Loev B; Musser JH; Brown RE; Jones H; Kahen R; Huang FC; Khandwala A; Sonnino-Goldman P; Leibowitz MJ
    J Med Chem; 1985 Mar; 28(3):363-6. PubMed ID: 2579236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pharmacological profile of a specific, safe, effective and non-sedative anti-allergic, astemizole.
    Niemegeers CJ; Awouters F; Janssen PA
    Agents Actions; 1986 Apr; 18(1-2):141-4. PubMed ID: 2873722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects.
    Matsushita N; Aritake K; Takada A; Hizue M; Hayashi K; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H
    Jpn J Pharmacol; 1998 Sep; 78(1):11-22. PubMed ID: 9804057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ketotifen: a histamine release inhibitor.
    Martin U; Roemer D
    Monogr Allergy; 1977; 12():145-9. PubMed ID: 72350
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917).
    Evans DP; Thomson DS
    Br J Pharmacol; 1975 Mar; 53(3):409-18. PubMed ID: 48393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levocabastine: pharmacological profile of a highly effective inhibitor of allergic reactions.
    Awouters F; Niemegeers CJ; Jansen T; Megens AA; Janssen PA
    Agents Actions; 1992 Jan; 35(1-2):12-8. PubMed ID: 1354927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay.
    Kubo N; Shirakawa O; Kuno T; Tanaka C
    Jpn J Pharmacol; 1987 Mar; 43(3):277-82. PubMed ID: 2884340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ro 21-7634, a new antiallergic agent with potent oral activity.
    Salvador RA; Czyzewski LB; Baruth H; Hooper A; Medford A; Miller D; van Trabert T; Yaremko B; Welton AF
    Agents Actions; 1981 Jul; 11(4):339-44. PubMed ID: 7025596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonist.
    Fleisch JH; Rinkema LE; Haisch KD; Whitesitt CA
    Agents Actions; 1987 Feb; 20(1-2):40-9. PubMed ID: 2883850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Newer antihistaminic agents.
    Norman PS
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):366-8. PubMed ID: 2862177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.